HOME >> MEDICINE >> NEWS
The European Cancer Patient Coalition - challenges for the future

The emergence of cross-Europe policies on health and related issues mean that cancer patients need a voice at European level, said a leading patient advocate at ECCO 12 The European Cancer Conference in Copenhagen today (Tuesday 23 September). But, according to Kathy Redmond, Editor, Cancer Futures, from Milan, Italy, there are many challenges to be faced in building an effective patient organisation, and the newly-launched European Cancer Patient Coalition (ECPC) will have to consider how best to tackle them.

At a European level it is difficult to define common concerns because of the variability of health care systems, she said. The European legislative system is extremely complicated, even to Brussels insiders, and ECPC will have to learn how to navigate and influence it.

But one of the largest obstacles to patient collaboration at European level is language. "Relatively few Europeans have the same mother tongue, with just over 25% speaking German, and 16% speaking English. Just over 50% of Europeans claim to speak a second language with around 40% speaking English, 10% German, 7% Spanish, and 3% Italian." Additionally, fluency in English as a second language declines with age, Ms Redmond said.

Linguistic difficulties also contribute to the digital divide in Europe. "Given that 70% of the content of the internet is in English, it is not surprising that there is a huge variation in the number of houses with internet access across Europe. In countries with high levels of English fluency such as the Netherlands, Sweden and Denmark, around 65% of households have internet access. But in Greece, Spain and Portugal internet access at home is as low as 9%. According to the latest Eurobarometer study, an average of only 25% of Europeans get health information from the internet," she said.

Funding is another problem for patient organisations, and one of the biggest challenges facing ECPC will be to ensure adequate funding to overcome th
'"/>

Contact: Mary Rice
mary.rice@blueprintpartners.be
45-3252-4163
Federation of European Cancer Societies
23-Sep-2003


Page: 1 2

Related medicine news :

1. ESC releases the first European Guidelines on Percutaneous Coronary Interventions (PCI)
2. The European Society of Cardiology launches Women at Heart
3. Use of potentially inappropriate medications among elderly common in some European countries
4. European folic acid policies are not effective enough
5. New European cancer figures for 2004 major efforts needed against the big four killers
6. Third of European cancer patients use complementary and alternative therapies
7. A new service from the European Patent Office
8. European study highlights persistent 3 decade increase in childhood cancer incidence
9. European nations urged to ratify international treaty on tobacco control
10. Increased investment in radiotherapy will improve cure rates for European cancer patients
11. ESA looking for more European women to volunteer for WISE bed-rest study in Toulouse next year

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The European Cancer Patient Coalition challenges for the future

(Date:4/17/2014)... School of Medicine report that older women, plucky individuals ... are more likely to be compassionate toward strangers than ... this month,s issue of the International Journal of ... with better health and well-being as we age, the ... outcomes of individuals whose deficits in compassion put them ...
(Date:4/17/2014)... the April issue of Immunity , Kevin J. ... Research, says it,s time to take a fresh look ... sepsis, which kills millions worldwide every year, including more ... into the bloodstream to fight an injury or infection ... maintaining good health without inflammation, wounds and infections ...
(Date:4/17/2014)... synthetic biology team has created a new technology ... that could travel the body and selectively target ... cell-based, biological devices that monitor and modify human ... biology. However, no existing technology enabled bioengineers to ... state and respond in a customized fashion. , ...
(Date:4/17/2014)... 17, 2014) Doctors who treat patients with ... (LAM) can face an agonizing treatment decision. , ... disease and help relieve shortness of breath. But ... sirolimus can cause potentially fatal complications following transplantation. ... Daniel Dilling, medical director of Loyola University Medical ...
(Date:4/17/2014)... NY (April 16, 2014) The cause of neuronal ... new study proposes that neurons may be mistaken for ... system, similar to the way autoimmune diseases like type ... body,s cells. The study was published April 16, 2014, ... new, and likely controversial, idea in Parkinson,s disease; but ...
Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Building 'smart' cell-based therapies 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Is Parkinson's an autoimmune disease? 2
(Date:1/15/2014)... Jan. 15, 2014  Zafgen, Inc., a leading biopharmaceutical ... severely obese patients, today announced initial results from ... inhibitor of methionine aminopeptidase 2 (MetAP2), in patients ... genetic obesity.  These results showed improvements in body ...
(Date:1/14/2014)... Texas , Jan. 14, 2014  Luminex Corporation (Nasdaq: ... results for the fourth quarter of 2013 on Monday, February ... for release after the close of trading. ... conference call to discuss the operating highlights and financial results ...
(Date:1/14/2014)... Healthcare Services, Inc. ("DHS"), a portfolio company of GMH Ventures ... Equipment, Inc. ("Progressive") of Clarion, PA ... not disclosed. Progressive is a full service ... sleep, mobility, and respiratory products to customers in the western ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
Cached News: